Literature DB >> 33067746

A Propensity Score-Matched Cohort Study to Evaluate the Association of Lymph Node Retrieval with Long-Term Overall Survival in Patients with Esophageal Cancer.

Leonie R van der Werf1,2, Elske Marra3, Suzanne S Gisbertz4, Bas P L Wijnhoven5, Mark I van Berge Henegouwen4.   

Abstract

BACKGROUND: Previous studies evaluating the association of lymph node (LN) yield and survival presented conflicting results and many may be influenced by confounding and stage migration.
OBJECTIVE: This study aimed to evaluate whether the quality indicator 'retrieval of at least 15 LNs' is associated with better long-term survival and more accurate pathological staging in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy and resection.
METHODS: Data of esophageal cancer patients who underwent neoadjuvant chemoradiotherapy and surgery between 2011 and 2016 were retrieved from the Dutch Upper Gastrointestinal Cancer Audit. Patients with < 15 and ≥ 15 LNs were compared after propensity score matching based on patient and tumor characteristics. The primary endpoint was 3-year survival. To evaluate the effect of LN yield on the accuracy of pathological staging, pathological N stage was evaluated and 3-year survival was analyzed in a subgroup of patients with node-negative disease.
RESULTS: In 2260 of 3281 patients (67%) ≥ 15 LNs were retrieved. In total, 992 patients with ≥ 15 LNs were matched to 992 patients with < 15 LNs. The 3-year survival did not differ between the two groups (57% vs. 54%; p = 0.28). pN+ was scored in 41% of patients with ≥ 15 LNs versus 35% of patients with < 15 LNs. For node-negative patients, the 3-year survival was significantly better for patients with ≥ 15 LNs (69% vs. 61%, p = 0.01).
CONCLUSIONS: n this propensity score-matched cohort, 3-year survival was comparable for patients with ≥ 15 LNs, although increasing nodal yield was associated with more accurate staging. In node-negative patients, 3-year survival was higher for patients with ≥ 15 LNs.

Entities:  

Year:  2020        PMID: 33067746      PMCID: PMC7752882          DOI: 10.1245/s10434-020-09142-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis.

Authors:  Els Visser; Sheraz R Markar; Jelle P Ruurda; George B Hanna; Richard van Hillegersberg
Journal:  Ann Surg       Date:  2019-02       Impact factor: 12.969

2.  Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit.

Authors:  L A D Busweiler; B P L Wijnhoven; M I van Berge Henegouwen; D Henneman; N C T van Grieken; M W J M Wouters; R van Hillegersberg; J W van Sandick
Journal:  Br J Surg       Date:  2016-10-05       Impact factor: 6.939

3.  Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.

Authors:  Ben M Eyck; Barbera D Onstenk; Bo J Noordman; Daan Nieboer; Manon C W Spaander; Roelf Valkema; Sjoerd M Lagarde; Bas P L Wijnhoven; J Jan B van Lanschot
Journal:  Ann Surg       Date:  2020-02       Impact factor: 12.969

4.  A National Cohort Study Evaluating the Association Between Short-term Outcomes and Long-term Survival After Esophageal and Gastric Cancer Surgery.

Authors:  Leonie R van der Werf; Bas P L Wijnhoven; Laura F C Fransen; Johanna W van Sandick; Grard A P Nieuwenhuijzen; Linde A D Busweiler; Richard van Hillegersberg; Michel W J M Wouters; Misha D P Luyer; Mark I van Berge Henegouwen
Journal:  Ann Surg       Date:  2019-11       Impact factor: 12.969

5.  Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.

Authors:  Hui-Ju Ho; Hui-Shan Chen; Wei-Heng Hung; Po-Kuei Hsu; Shiao-Chi Wu; Heng-Chung Chen; Bing-Yen Wang
Journal:  Ann Surg Oncol       Date:  2018-10-03       Impact factor: 5.344

6.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.

Authors:  Jan B F Hulscher; Johanna W van Sandick; Angela G E M de Boer; Bas P L Wijnhoven; Jan G P Tijssen; Paul Fockens; Peep F M Stalmeier; Fiebo J W ten Kate; Herman van Dekken; Huug Obertop; Hugo W Tilanus; J Jan B van Lanschot
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

7.  Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Chenxue Jiang; Yun Chen; Yaoyao Zhu; Yapping Xu
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

8.  A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit.

Authors:  L R van der Werf; J L Dikken; M I van Berge Henegouwen; V E P P Lemmens; G A P Nieuwenhuijzen; B P L Wijnhoven
Journal:  Ann Surg Oncol       Date:  2018-03-09       Impact factor: 5.344

9.  Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.

Authors:  Eliza R C Hagens; Mark I van Berge Henegouwen; Johanna W van Sandick; Miguel A Cuesta; Donald L van der Peet; Joos Heisterkamp; Grard A P Nieuwenhuijzen; Camiel Rosman; Joris J G Scheepers; Meindert N Sosef; Richard van Hillegersberg; Sjoerd M Lagarde; Magnus Nilsson; Jari Räsänen; Philippe Nafteux; Piet Pattyn; Arnulf H Hölscher; Wolfgang Schröder; Paul M Schneider; Christophe Mariette; Carlo Castoro; Luigi Bonavina; Riccardo Rosati; Giovanni de Manzoni; Sandro Mattioli; Josep Roig Garcia; Manuel Pera; Michael Griffin; Paul Wilkerson; M Asif Chaudry; Bruno Sgromo; Olga Tucker; Edward Cheong; Krishna Moorthy; Thomas N Walsh; John Reynolds; Yuji Tachimori; Haruhiro Inoue; Hisahiro Matsubara; Shin-Ichi Kosugi; Haiquan Chen; Simon Y K Law; C S Pramesh; Shailesh P Puntambekar; Sudish Murthy; Philip Linden; Wayne L Hofstetter; Madhan K Kuppusamy; K Robert Shen; Gail E Darling; Flávio D Sabino; Peter P Grimminger; Sybren L Meijer; Jacques J G H M Bergman; Maarten C C M Hulshof; Hanneke W M van Laarhoven; Banafsche Mearadji; Roel J Bennink; Jouke T Annema; Marcel G W Dijkgraaf; Suzanne S Gisbertz
Journal:  BMC Cancer       Date:  2019-07-04       Impact factor: 4.430

10.  Extent of lymphadenectomy in esophageal cancer: how many lymph nodes is enough?

Authors:  Luis J Herrera
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

View more
  1 in total

1.  Esophageal leiomyoma and simultaneous overlying squamous cell carcinoma: a case report and review of the literature.

Authors:  Saadat Mehrabi; Mohammad Javad Yavari Barhaghtalab; Safoora Hejazinia; Hossein Saedi
Journal:  BMC Surg       Date:  2021-04-29       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.